Literature DB >> 22116443

Syndrome of inappropriately low-pressure acute hydrocephalus (SILPAH).

Mark G Hamilton1, Angel V Price.   

Abstract

INTRODUCTION: Most patients with acute hydrocephalus have ventriculomegaly and high intracranial pressure (ICP). However, there is a subset of patients who are symptomatic with acute ventriculomegaly and inappropriately low ICP.
METHODS: Two patient groups were defined. Each patient presented with clinical deterioration that included a significant decrease in level of consciousness with new and significant ventriculomegaly. Patients in group 1 (n = 10) were managed without endoscopic third ventriculostomy (ETV). Group 2 was a series of patients (n = 10) managed with ETV.
RESULTS: Treatment for both groups involved insertion of an external ventricular drain (EVD) with ICP <5 cmH(2)O. Further treatment consisted of either neck wrapping with a tensor bandage and/or lowering the EVD to negative levels to facilitate drainage of cerebrospinal fluid (CSF), which resulted in clinical improvement and resolution of ventriculomegaly. All 20 patients had anatomical obstruction to CSF flow into the subarachnoid space (SAS) confirmed by magnetic resonance imaging (MRI) with cine MRI studies. Group 1 patients were treated until shunt revision/insertion was possible (n = 7), ICP normalized, and the EVD could be removed (n = 2), or death (n = 1) occurred. Patients in group 2 all underwent ETV, and ICP patterns normalized in all. Group 2 patients were managed with an EVD until shunt revision/insertion was required (n = 2), ICP normalized and the EVD could be removed (n = 7), or death (n = 1) occurred. DISCUSSION/
CONCLUSIONS: The syndrome of inappropriately low-pressure acute hydrocephalus (SILPAH) is an important entity in both children and adults. A possible hypothesis invokes loss of an effective SAS. ETV reestablishes communication between the SAS and ventricles, producing a rapid return of normal ICP dynamics and a significant decrease in the number of shunt-dependent patients.

Entities:  

Mesh:

Year:  2012        PMID: 22116443     DOI: 10.1007/978-3-7091-0923-6_31

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  7 in total

Review 1.  Pathogenesis of hydrocephalus in achondroplastic dwarfs: a review and presentation of a case followed for 22 years.

Authors:  Harold L Rekate
Journal:  Childs Nerv Syst       Date:  2019-06-21       Impact factor: 1.475

2.  MR Elastography Can Be Used to Measure Brain Stiffness Changes as a Result of Altered Cranial Venous Drainage During Jugular Compression.

Authors:  A Hatt; S Cheng; K Tan; R Sinkus; L E Bilston
Journal:  AJNR Am J Neuroradiol       Date:  2015-06-04       Impact factor: 3.825

3.  Importance of Frontal Horn Ratio and Optimal CSF Drainage in the Treatment of Very Low-Pressure Hydrocephalus.

Authors:  Danielle Houlden; Dmitriy Khodorskiy; Sandra Miller-Portman; Maria Li
Journal:  J Neurol Surg B Skull Base       Date:  2017-12-11

Review 4.  Normal pressure hydrocephalus as a failure of ICP homeostasis mechanism: the hidden role of Monro-Kellie doctrine in the genesis of NPH.

Authors:  Asem Salma
Journal:  Childs Nerv Syst       Date:  2014-02-28       Impact factor: 1.475

5.  Commentary on the article "Brain stiffness following recovery in a patient with an episode of low-pressure hydrocephalus: case report".

Authors:  Harold L Rekate
Journal:  Childs Nerv Syst       Date:  2021-07-16       Impact factor: 1.475

6.  Low-Pressure Hydrocephalus and Shunt Malfunction Following a Lumbar Puncture in an Adult Reversed by an Epidural Blood Patch.

Authors:  Marcelo D Vilela; Hugo As Pedrosa; Braulio F Mesquita; Claudia L F Horiguchi
Journal:  World Neurosurg       Date:  2020-07-23       Impact factor: 2.104

7.  Endoscopic third ventriculostomy as adjunctive therapy in the treatment of low-pressure hydrocephalus in adults.

Authors:  Kimberly A Foster; Christopher P Deibert; Phillip A Choi; Paul A Gardner; Elizabeth C Tyler-Kabara; Johnathan A Engh
Journal:  Surg Neurol Int       Date:  2016-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.